NCT02356822

Brief Summary

This is an investigational multi-site outcomes registry intended to collect information about a patient's cancer care. Patients may enter the Registry at any time during the patient's current stage in the continuum of care. The registries main objectives will be to measure and evaluate the effects of patient care throughout the care continuum, resulting in the identification of the most effective treatment options. Objectives will encompass evaluations and analytics around safety, effectiveness, and improved efficiencies.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Dec 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2014

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 20, 2015

Completed
16 days until next milestone

First Posted

Study publicly available on registry

February 5, 2015

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

December 5, 2023

Status Verified

June 1, 2019

Enrollment Period

5 years

First QC Date

January 20, 2015

Last Update Submit

December 1, 2023

Conditions

Oncology

Outcome Measures

Primary Outcomes (2)

  • quality improvement

    10 yrs

  • Treatment patterns and utilization

    5 yrs

Secondary Outcomes (1)

  • Humanistic and economic outcomes

    10 yrs

Other Outcomes (1)

  • safety and effectiveness

    10 yrs

Interventions

Patient registryOTHER

Oncology data registry

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients 18yrs or older, that have been diagnosed with/ or are thought to have any form of cancer at any stage in the continuum of their care from screening through survivorship. Patient must have the ability to understand the nature of the trial and give written informed consent.

You may qualify if:

  • or older
  • Patients that have been diagnosed with/ or are thought to have any form of cancer at any stage in the continuum of their care from screening through survivorship.
  • Patient must have the ability to understand the nature of the trial and give written informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

SCRI

Nashville, Tennessee, 37203, United States

Location

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Richard Geer, MD

    Sarah Cannon

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 20, 2015

First Posted

February 5, 2015

Study Start

December 1, 2014

Primary Completion

December 1, 2019

Study Completion

December 1, 2024

Last Updated

December 5, 2023

Record last verified: 2019-06

Locations

US(1)